GT
OPTN

Glenmede Trust’s OptiNose OPTN Stock Holding History

Glenmede Trust’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150
Closed -$8K – 1922
2020
Q3 		$8K Hold
150
– – ﹤0.01% 1964
2020
Q2 		$16K Sell
150
-134
-47% -$9.54K ﹤0.01% 1680
2020
Q1 		$39K Hold
284
– – ﹤0.01% 1790
2019
Q4 		$39K Hold
284
– – ﹤0.01% 1790
2019
Q3 		$29 Hold
284
– – ﹤0.01% 1881
2019
Q2 		$30 Hold
284
– – ﹤0.01% 1904
2019
Q1 		$43 Hold
284
– – ﹤0.01% 1747
2018
Q4 		$26 Buy
+284
New +$40.6K ﹤0.01% 1866

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Glenmede Trust's OPTN Position: Q4 2020 in Review

Glenmede Trust sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 150 shares — an estimated $8K sold.

Glenmede Trust first reported a position in OPTN in Q4 2018 and held it in 8 quarters. The position peaked at $39K in Q1 2020. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • Glenmede Trust reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 150 OptiNose shares in Q4 2020, an estimated $8K.
  • Glenmede Trust first reported a position in OptiNose in Q4 2018 and held it in 8 quarters.
  • Glenmede Trust's OptiNose position peaked at $39K in Q1 2020.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.